GLP-1/glucagon dual agonistGLP-1 Agonists
Pemvidutide
A dual GLP-1/glucagon receptor agonist by Altimmune for obesity and NASH/MASH. The glucagon component increases energy expenditure and hepatic fat oxidation. Phase 2 showed 15.6% weight loss at 48 weeks with liver fat reduction.
weight-lossGLP-1glucagonNASHliver-fat-reduction
3D Structure
3D Structure
Lab Tested
No
Harmful Ingredients
0
Contaminants
None
Tested Purity
--
Batch Consistency
No batch data
Mass Spec Profile
No mass spec data
Batch Info
Latest Batch—
Total Tests0
Unique Vendors0
Vendor Comparison
No vendor data yet
Analysis Summary
Purity Standard
No purity dataLab Reports
0 reports on file
Summary
A dual GLP-1/glucagon receptor agonist by Altimmune for obesity and NASH/MASH. The glucagon component increases energy expenditure and hepatic fat oxidation. Phase 2 showed 15.6% weight loss at 48 wee…